AU2259999A - Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation - Google Patents
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenationInfo
- Publication number
- AU2259999A AU2259999A AU22599/99A AU2259999A AU2259999A AU 2259999 A AU2259999 A AU 2259999A AU 22599/99 A AU22599/99 A AU 22599/99A AU 2259999 A AU2259999 A AU 2259999A AU 2259999 A AU2259999 A AU 2259999A
- Authority
- AU
- Australia
- Prior art keywords
- hepatic
- oxygenation
- reversal
- aging
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU22599/99A AU2259999A (en) | 1998-01-30 | 1999-02-01 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP1542A AUPP154298A0 (en) | 1998-01-30 | 1998-01-30 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
AUPP1542 | 1998-01-30 | ||
AUPP7619A AUPP761998A0 (en) | 1998-12-09 | 1998-12-09 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation |
AUPP7619 | 1998-12-09 | ||
AUPP7701 | 1998-12-11 | ||
AUPP7701A AUPP770198A0 (en) | 1998-12-11 | 1998-12-11 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation |
AU22599/99A AU2259999A (en) | 1998-01-30 | 1999-02-01 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
PCT/AU1999/000065 WO1999038507A1 (en) | 1998-01-30 | 1999-02-01 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2259999A true AU2259999A (en) | 1999-08-16 |
Family
ID=27422725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22599/99A Abandoned AU2259999A (en) | 1998-01-30 | 1999-02-01 | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2259999A (en) |
-
1999
- 1999-02-01 AU AU22599/99A patent/AU2259999A/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL183948A0 (en) | Conjugates of peg-urate oxidase and use thereof | |
AU1606900A (en) | Non-electrolytic gold plating compositions and methods of use thereof | |
AU1920900A (en) | Solid water treatment composition and methods of preparation and use | |
PL342892A1 (en) | Remineralization of teeth | |
HUP0002493A3 (en) | Use of colchinol derivatives as vascular damaging agents and certain new compounds | |
EP1076547A4 (en) | Derivatives of arabinogalactan and compositions including the same | |
EP1129217A4 (en) | Compositions and methods of disease diagnosis and therapy | |
AU3118499A (en) | Soft tissue reconstructor and method of use | |
HUP0000963A3 (en) | The use of levobupivacaine in paediatric surgery | |
AU2001257406A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | |
IL138672A0 (en) | Liposomal bupivacaine compositions and methods of preparation | |
AU3671999A (en) | Combination of main scrubbing machine and attachment scrubbing machine | |
AU7277798A (en) | Use of sialyl galactosides and related compounds as anti-angiogenic agents | |
AU6412599A (en) | Oxybutynin formulations and methods of use | |
IL137836A0 (en) | Methods and compositions for diagnosis of hepatoma | |
AU2259999A (en) | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation | |
AUPP154298A0 (en) | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation | |
AUPP770198A0 (en) | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation | |
AUPP761998A0 (en) | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation | |
AU6593100A (en) | Interdental brush and interdental brush set | |
AU3964499A (en) | Agouti-related protein analogs and methods of use | |
AU5226798A (en) | Use of paracetamol as depigmenting agent | |
AU3774100A (en) | Heat-activated cleaning compositions with wrinkle-resistance and methods of use | |
TW406556U (en) | Improvement of dental floss structure | |
AU4207899A (en) | Lentiviral vector compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |